All News about Altria Group
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
December 20, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Altria Abandons Expiring Cronos Warrant; Maintains Initial Investment
December 19, 2022
From Altria Group, Inc.
Via Business Wire
Altria Declares Regular Quarterly Dividend of $0.94 Per Share
December 07, 2022
From Altria Group, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|